Published by Alexander Bueso on 10th March 2021
(Sharecast News) - Eli Lilly's combination antibody therapy against Covid-19 reduces the risk of death or hospitalisation by well over four fifths among high-risk patients, the results of a study showed.
URL: http://www.digitallook.com/dl/news/story/31699935/...